The meta-analysis by Chan et al. found that the positive association with circulating CRP concentration was similar when focused only on postmenopausal breast cancer risk (RR 1.06, 95% CI: 1.01, 1.11); numbers were too small to assess premenopausal breast cancer separately [23]. The gene discussed is CRP; the disease is breast carcinoma.